Oxford Gene Technology Grants Microarray Licence to BF-BIOlabs
News Sep 29, 2008
Oxford Gene Technology (OGT) and BF-BIOlabs have announced the completion of a licensing agreement granting BF-BIOlabs access to OGT’s “Southern array patents”, the fundamental patents covering the manufacture and marketing of oligonucleotide microarrays.
The granted licence will enable BF-BIOlabs to sell arrays and provide services that include the design and production of custom-made microarrays for gene-identification, single nucleotide polymorphisms (SNP) and gene expression analysis.
Susan Sutton, Vice President Licensing (North America and Europe) at OGT, said: “OGT continues to grow its microarray licensee portfolio in Europe and this in turn will enable companies to expand their business activities and make microarray technology more accessible.”
BF-BIOlabs designs and produces custom-made microarrays for gene-identification, SNP, and gene-expression analysis, using specialized microarray production processes to achieve optimal specificity and sensitivity. In addition, BF-BIOlabs offers a full service for microarray experiments, chip readout and data analysis.
The licence will remain valid for the patents’ lifetime. Financial details were not disclosed.
Measuring Neutrophil Motility Could Lead to Accurate Sepsis DiagnosisNews
Mass. General researchers design device that rapidly diagnoses sepsis with more than 95 percent accuracy.READ MORE
Largest Genetic Study of Osteoarthritis Advances ResearchNews
Osteoarthritis is a complex disease, and the genetic basis of the disease has proved difficult to pin down. A new study from the Sanger Institute provides much-needed hope.READ MORE
Comments | 0 ADD COMMENT
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
International Conference on Molecular Biology and Stem Cells
Aug 13 - Aug 15, 2018